Related Experiment Video

Updated: Aug 18, 2026

Live Dissection of Drosophila Embryos: Streamlined Methods for Screening Mutant Collections by Antibody Staining
13:48

Live Dissection of Drosophila Embryos: Streamlined Methods for Screening Mutant Collections by Antibody Staining

Published on: December 29, 2009

Keeping the receptor tyrosine kinase signaling pathway in check: lessons from Drosophila

Ilaria Rebay1

  • 1Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge 02142, USA. rebay@wi.mit.edu

Developmental Biology
|November 5, 2002
PubMed

Insights

Receptor tyrosine kinase (RTK) signaling is tightly controlled by inhibitory mechanisms. This review highlights threshold regulation and negative feedback loops, essential for preventing uncontrolled cell growth and cancer.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Developmental Biology

Background:

  • Receptor tyrosine kinase (RTK) signaling is crucial for cell differentiation, proliferation, and survival in metazoans.
  • Dysregulated RTK activation is implicated in mammalian carcinogenesis, necessitating robust inhibitory control.
  • Understanding these regulatory mechanisms is vital for addressing diseases linked to aberrant signaling.

Purpose of the Study:

  • To review inhibitory mechanisms regulating RTK signaling.
  • To emphasize conserved principles of RTK regulation using Drosophila as a model.
  • To elucidate strategies that prevent uncontrolled RTK pathway activation.

Main Methods:

  • Review of existing literature on RTK signaling and its regulation.
  • Focus on conserved inhibitory mechanisms identified in Drosophila.
  • Analysis of two primary inhibition strategies: threshold regulation and negative feedback loops.

Main Results:

  • RTK signaling is controlled through threshold regulation, establishing barriers against inappropriate responses.
  • Negative feedback loops are induced to limit signal extent, strength, and duration.
  • These mechanisms operate from the receptor level to downstream effectors, ensuring signal attenuation.

Conclusions:

  • Conserved inhibitory mechanisms, including threshold regulation and negative feedback, are critical for maintaining RTK signaling homeostasis.
  • These strategies prevent uncontrolled signaling, thereby mitigating the risk of carcinogenesis.
  • Drosophila serves as a valuable model for dissecting these fundamental biological processes.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Visualizing Low-Abundance Proteins and Post-Translational Modifications in Living Drosophila Embryos via Fluorescent Antibody Injection07:15

Visualizing Low-Abundance Proteins and Post-Translational Modifications in Living Drosophila Embryos via Fluorescent Antibody Injection

Published on: January 19, 2024

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...